Wildcat Capital Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.79M Hold
495,606
4.03% 4
2025
Q1
$5.48M Hold
495,606
2.93% 4
2024
Q4
$5.28M Hold
495,606
2.09% 4
2024
Q3
$6.29M Hold
495,606
3.08% 4
2024
Q2
$8.32M Hold
495,606
2.04% 9
2024
Q1
$7.43M Hold
495,606
2.7% 10
2023
Q4
$7.43M Hold
495,606
2.57% 11
2023
Q3
$6.94M Hold
495,606
2.79% 11
2023
Q2
$5.13M Hold
495,606
1.95% 14
2023
Q1
$4.58M Sell
495,606
-37,533
-7% -$347K 1.7% 15
2022
Q4
$4.73M Hold
533,139
1.81% 15
2022
Q3
$4.44M Hold
533,139
1.7% 17
2022
Q2
$4.37M Hold
533,139
1.45% 17
2022
Q1
$4.64M Hold
533,139
1.19% 16
2021
Q4
$5.07M Hold
533,139
0.83% 15
2021
Q3
$8.97M Hold
533,139
1.16% 18
2021
Q2
$8.14M Hold
533,139
0.92% 15
2021
Q1
$10.4M Sell
533,139
-719,146
-57% -$14M 1.27% 14
2020
Q4
$22.6M Hold
1,252,285
2.84% 9
2020
Q3
$24.2M Buy
1,252,285
+352,137
+39% +$6.79M 7.72% 5
2020
Q2
$23.5M Hold
900,148
8.12% 4
2020
Q1
$16.1M Sell
900,148
-255,714
-22% -$4.56M 7.31% 5
2019
Q4
$38.6M Buy
1,155,862
+99,800
+9% +$3.33M 11.13% 3
2019
Q3
$25.2M Buy
1,056,062
+212,697
+25% +$5.07M 10.69% 2
2019
Q2
$30.3M Buy
843,365
+64,362
+8% +$2.31M 13.12% 2
2019
Q1
$28.8M Buy
779,003
+166,509
+27% +$6.15M 16.87% 2
2018
Q4
$26.4M Buy
612,494
+237,015
+63% +$10.2M 17.34% 2
2018
Q3
$17.7M Buy
375,479
+124,020
+49% +$5.86M 13.68% 2
2018
Q2
$12.5M Buy
251,459
+69,757
+38% +$3.47M 9.57% 4
2018
Q1
$9.03M Buy
181,702
+54,389
+43% +$2.7M 7.45% 4
2017
Q4
$4.74M Sell
127,313
-7,687
-6% -$286K 5.04% 5
2017
Q3
$4.26M Hold
135,000
0.76% 10
2017
Q2
$2.44M Buy
+135,000
New +$2.44M 0.65% 12